Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2022

View Archived Issues

Peptide-based radiopharmaceutical with reduced kidney and healthy tissue uptake

Therapeutic effects of 177Lu-ofatumumab in lymphoma murine model

CHM-273S peptide shows promise as antidiabetic drug in rats

Pathogenic variants in PRRX1 gene associated with craniosynostosis

HISHS-3001, a novel tri-receptor agonist with improved efficacy in diabetic mice

Merck & Co. patents new GTPase KRAS inhibitors

Peking University divulges new transcription factor PU.1 inhibitors

OR-449 differentially regulates sulfation pathway genes in ACC

Vertex Pharmaceuticals discloses new CFTR modulators

Enanta Pharmaceuticals identifies new SARS-CoV-2 3C-like proteinase inhibitors

Gossamer Bio presents Janus kinase inhibitors

TULP3 mutations cause degeneration of major organs

Combinatorial analytics identifies hundreds of precise drug repositioning opportunities

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...